1. What is the beta-alanine market size in 2024?
The global beta-alanine market was valued at USD 96.3 million in 2024 and is projected to reach USD 147.3 million by 2034, growing at a CAGR of 4.3%.
+1 2315155523
Market Lens IQ is a global market intelligence and strategic consulting firm delivering advanced syndicated research reports, customized industry analysis, competitive intelligence, and data-driven advisory solutions to organizations across international markets. With a strong commitment to analytical excellence and innovation, Market Lens IQ empowers enterprises, investors, consultants, and decision-makers with actionable insights that drive strategic growth, operational efficiency, and long-term business transformation in highly competitive industries. The company serves a broad spectrum of industry verticals, including Life Sciences, Consumer Goods, Semiconductor and Electronics, Materials and Chemicals, Construction and Manufacturing, Food and Beverages, Energy and Power, Automotive and Transportation, ICT and Media, Aerospace and Defense, and BFSI (Banking, Financial Services, and Insurance). By combining deep domain expertise with advanced analytics, Market Lens IQ delivers comprehensive market assessments, technology trend analysis, investment intelligence, supply chain insights, pricing analysis, customer behavior studies, and future market forecasts tailored to evolving business requirements.
At the core of Market Lens IQ’s capabilities lies a robust 360-degree research methodology integrating primary research, secondary research, expert interviews, data triangulation, AI- powered analytics, and real-time market monitoring. Our research framework ensures the highest standards of data accuracy, reliability, and strategic relevance by leveraging industry databases, corporate filings, government publications, trade journals, regulatory frameworks, white papers, investor presentations, and global economic indicators. The company specializes in identifying emerging market opportunities, disruptive technologies, innovation ecosystems, competitive benchmarking, regulatory shifts, and high-growth investment segments across global industries. Driven by a client-centric approach, Market Lens IQ collaborates with startups, SMEs, multinational enterprises, private equity firms, institutional investors, and Fortune 500 companies to deliver high-value business intelligence solutions that support informed decision-making and sustainable competitive advantage. Through continuous innovation, digital intelligence capabilities, and industry-focused expertise, Market Lens IQ has established itself as a trusted strategic partner in the global market research and consulting landscape, helping organizations navigate market complexities and capitalize on transformative growth opportunities.
Senior Analyst


The global beta-alanine market is estimated at USD 96.3 million in 2024 and is projected to reach USD 147.3 million by 2034, expanding at a CAGR of 4.3% over the forecast period (2025–2034). This growth is underpinned by sustained demand from sports nutrition, dietary supplements, and functional food and beverage applications.
Beta-alanine, a non-essential amino acid, serves as the rate-limiting precursor to carnosine, which buffers hydrogen ions in muscle tissue and delays fatigue during high-intensity exercise. Its efficacy in improving muscular endurance has cemented its position as a staple ingredient in pre-workout and performance-enhancing formulations.
Our proprietary primary research, incorporating interviews with 120+ industry stakeholders across the value chain, indicates that product innovation, clean-label formulations, and e-commerce penetration will shape competitive dynamics through 2034.
| Grade | 2024 Revenue (USD Million) | Share | Key Applications |
|---|---|---|---|
| Food Grade | 47.5 | 49.3% | Energy drinks, functional foods, supplements |
| Pharmaceutical Grade | 28.9 | 30.0% | Clinical nutrition, therapeutic formulations |
| Feed Grade | 19.9 | 20.7% | Poultry and livestock feed additives |
| Application | Market Share (2024) | Growth Outlook |
|---|---|---|
| Dietary Supplements | 51% | Moderate (CAGR ~4.5%) |
| Pharmaceuticals | 18% | High (CAGR ~5.0%) |
| Food & Beverages | 15% | High (CAGR ~5.2%) |
| Cosmetics | 8% | Moderate (CAGR ~3.8%) |
| Animal Feed | 8% | High (CAGR ~5.5%) |
| Region | 2024 Market Size (USD Million) | Share | CAGR (2025–2034) |
|---|---|---|---|
| North America | 27.0 | 28.0% | 4.0% |
| Europe | 21.2 | 22.0% | 3.8% |
| Asia-Pacific | 35.6 | 37.0% | 5.2% |
| South America | 6.7 | 7.0% | 4.5% |
| Middle East & Africa | 5.8 | 6.0% | 4.7% |
The beta-alanine market is moderately consolidated, with leading companies focusing on:
Our primary research indicates that 65% of surveyed manufacturers plan to increase R&D spending on beta-alanine applications in pharmaceuticals and animal feed over the next three years.
Global trade in beta-alanine is characterized by intra-industry flows, with China emerging as the largest exporter of raw beta-alanine and finished ingredients. According to UN Comtrade data, China accounted for approximately 42% of global beta-alanine exports by volume in 2023, followed by Europe (28%) and North America (18%).
| Region | Market Attractiveness | Key Opportunities | Risk Factors |
|---|---|---|---|
| Asia-Pacific | High | Rising fitness culture, expanding supplement market, low production costs | Regulatory fragmentation, counterfeit products |
| North America | Moderate | Premiumization, clean-label innovation, clinical research | Market maturity, intense competition |
| Europe | Moderate | Functional food applications, strict quality standards | Regulatory complexity, high compliance costs |
| South America | Emerging | Growing sports nutrition adoption, feed additives | Economic volatility, import dependence |
| Middle East & Africa | Emerging | Poultry feed supplementation, rising health awareness | Limited infrastructure, political instability |
| Aspects | Details |
|---|---|
| Study Period | 2020-2034 |
| Base Year | 2025 |
| Estimated Year | 2026 |
| Forecast Period | 2026-2034 |
| Historical Period | 2020-2025 |
| Growth Rate | CAGR of 4.3% from 2020-2034 |
| Segmentation |
|
Our rigorous research methodology combines multi-layered approaches with comprehensive quality assurance, ensuring precision, accuracy, and reliability in every market analysis.
| Stakeholder Role | Interview Share (%) |
|---|---|
| Procurement Director | 30% |
| R&D Manager | 25% |
| Product Development Head | 20% |
| Regulatory Affairs Specialist | 15% |
| Marketing Director | 10% |
| Company Type | Representation (%) |
|---|---|
| Raw Material Suppliers | 25% |
| Ingredient Manufacturers | 30% |
| Supplement Brand Owners | 25% |
| Distributors & Retailers | 15% |
| Regulatory & Research Bodies | 5% |
The global beta-alanine market was valued at USD 96.3 million in 2024 and is projected to reach USD 147.3 million by 2034, growing at a CAGR of 4.3%.
Asia-Pacific holds the largest share at 37% in 2024, driven by rising fitness awareness, expanding supplement markets, and low production costs in countries like China and India.
Beta-alanine is primarily used in dietary supplements (51% share), pharmaceuticals, food and beverages, cosmetics, and animal feed. The athletes and bodybuilders segment alone generated USD 37.3 million in 2024.
Powder form dominates with a 59.1% share in 2024, owing to its flexibility, ease of custom dosing, and widespread use in sports nutrition formulations.
Key players include Anhui Huaheng Biotechnology, Cellucor, Evlution Nutrition, Hi-Tech Pharmaceuticals, Natural Alternatives International, NOW Foods, Nutricost, Thorne Research, Ultimate Nutrition, and Yuki Gosei Kogyo.